These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 9360192)

  • 1. Increased nuchal translucency thickness in a fetus at risk for beta-thalassaemia.
    Makrydimas G; Georgiou I; Syrrou M; Skendou C; Lolis D
    J Matern Fetal Med; 1997; 6(5):301-2. PubMed ID: 9360192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency.
    Pandya PP; Kondylios A; Hilbert L; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):15-9. PubMed ID: 7850583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trisomy 18: first-trimester nuchal translucency with pathological correlation.
    Jackson S; Porter H; Vyas S
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):55-6. PubMed ID: 7850592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal nuchal translucency and prenatal diagnosis of beta-thalassaemia.
    Monni G; Ibba RM; Zoppi MA; Putzolu M; Floris M; Cao A
    Prenat Diagn; 1999 Aug; 19(8):758-60. PubMed ID: 10451523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Trisomy 18 anomalies on sonography and calculated risk of chromosomal abnormalities during first trimester].
    Maymon R; Herman A; Dreazen E; Glasner M; Weinraub Z
    Harefuah; 1998 Sep; 135(5-6):180-2, 256, 255. PubMed ID: 9885629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant results between fetal cell-free DNA in maternal plasma and chorionic villus sampling in a first-trimester fetus with increased nuchal translucency and megacystis.
    Sepulveda W
    Ultrasound Obstet Gynecol; 2014 Sep; 44(3):369. PubMed ID: 24832209
    [No Abstract]   [Full Text] [Related]  

  • 7. Trisomy 10: first-trimester features on ultrasound, fetoscopy and postmortem of a case associated with increased nuchal translucency.
    Schwärzler P; Moscoso G; Bernard JP; Hill L; Senat MV; Ville Y
    Ultrasound Obstet Gynecol; 1999 Jan; 13(1):67-70. PubMed ID: 10201090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness.
    Hyett JA; Sebire NJ; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Feb; 7(2):101-3. PubMed ID: 8776233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of first-trimester screening by fetal nuchal translucency and maternal age.
    Theodoropoulos P; Lolis D; Papageorgiou C; Papaioannou S; Plachouras N; Makrydimas G
    Prenat Diagn; 1998 Feb; 18(2):133-7. PubMed ID: 9516014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased nuchal translucency as a marker for fetal chromosomal defects.
    Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P
    N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester Down's syndrome screening using nuchal translucency: a prospective study in patients undergoing chorionic villus sampling.
    Brambati B; Cislaghi C; Tului L; Alberti E; Amidani M; Colombo U; Zuliani G
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):9-14. PubMed ID: 7850598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for fetal trisomy 21 in the first trimester of pregnancy: maternal serum free beta-hCG and fetal nuchal translucency thickness.
    Noble PL; Abraha HD; Snijders RJ; Sherwood R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Dec; 6(6):390-5. PubMed ID: 8903913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation.
    Snijders RJ; Sebire NJ; Nayar R; Souka A; Nicolaides KH
    Am J Med Genet; 1999 Sep; 86(3):205-7. PubMed ID: 10482866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal diagnosis of beta-thalassaemia by chorionic villous sampling.
    Tasleem S; Tasleem H; Siddiqui MA; Adil MM; Rashid Y
    J Pak Med Assoc; 2007 Nov; 57(11):528-31. PubMed ID: 18062515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-trimester fetal nuchal translucency thickness and risk for trisomies.
    Pandya PP; Brizot ML; Kuhn P; Snijders RJ; Nicolaides KH
    Obstet Gynecol; 1994 Sep; 84(3):420-3. PubMed ID: 8058241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
    Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histomorphological features of chorionic villi at 10-14 weeks of gestation in trisomic and chromosomally normal pregnancies.
    Roberts L; Sebire NJ; Fowler D; Nicolaides KH
    Placenta; 2000 Sep; 21(7):678-83. PubMed ID: 10985971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient increase in nuchal translucency thickness and reversed end-diastolic ductus venosus flow in a fetus with trisomy 18.
    Huisman TW; Bilardo CM
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):397-9. PubMed ID: 9476323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.